chr9-2029072-C-G
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_003070.5(SMARCA2):c.50C>G(p.Pro17Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000000707 in 1,415,106 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P17L) has been classified as Likely benign.
Frequency
Consequence
NM_003070.5 missense
Scores
Clinical Significance
Conservation
Publications
- intellectual disability-sparse hair-brachydactyly syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMARCA2 | NM_003070.5 | c.50C>G | p.Pro17Arg | missense_variant | Exon 2 of 34 | ENST00000349721.8 | NP_003061.3 | |
SMARCA2 | NM_001289396.2 | c.50C>G | p.Pro17Arg | missense_variant | Exon 2 of 34 | NP_001276325.1 | ||
SMARCA2 | NM_139045.4 | c.50C>G | p.Pro17Arg | missense_variant | Exon 2 of 33 | NP_620614.2 | ||
SMARCA2 | NM_001289397.2 | c.50C>G | p.Pro17Arg | missense_variant | Exon 2 of 33 | NP_001276326.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 7.07e-7 AC: 1AN: 1415106Hom.: 0 Cov.: 32 AF XY: 0.00000143 AC XY: 1AN XY: 699872 show subpopulations
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Uncertain:1
This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 17 of the SMARCA2 protein (p.Pro17Arg). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SMARCA2-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SMARCA2 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at